Insmed Inc. buy JPMorgan Chase & Co.
Start price
20.08.25
/
50%
€110.00
Target price
20.08.26
€116.07
Performance (%)
6.91%
Price
05.05.26
€119.20
Summary
This prediction is currently active. With a performance of 6.91%, the BUY prediction by JPMorgan_Chase___Co_ for Insmed Inc. is trending in the right direction. This prediction currently runs until 20.08.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 2.727% | 2.727% |
| iShares Core DAX® | 1.598% | 5.040% |
| iShares Nasdaq 100 | 3.742% | 14.947% |
| iShares Nikkei 225® | 3.736% | 13.892% |
| iShares S&P 500 | 1.816% | 8.879% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $111.00 to $135.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat